300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Retail
Oil and Gas
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Biotechnology
Software
Legal
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Climate
Fashion
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Music
Art
Real Estate
Sporting Goods
Manufacturing
Publishing
Mobile Apps
Wine and Spirits
Social Media
Financial Services
FinTech
Finance
Franchise
Digital Media
Non Profit
Android
Internet
Proptech
Mobile Advertising
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Zambia
Tajikistan
Romania
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Armenia
Colombia
China
Costa Rica
Kenya
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Panama
Nicaragua
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Morocco
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Paraguay
Canada
Botswana
South Africa
France
Ireland
Denmark
Georgia
Ghana
Iraq
Latvia
Malaysia
Mali
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Spain
Argentina
Europe
Qatar
Angola
Cyprus
Barbados
Belgium
Bangladesh
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Faroe Islands
Ecuador
Jersey
Bolivia
Bahrain
Belize
Algeria
Italy
Belarus
Finland
Hungary
Estonia
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Bahamas
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
Ukraine
San Marino
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database

BeOne Medicines Ltd.

VC Fund

Klein-basel, Switzerland

BeOne Medicines Ltd. is a VC fund in Klein-basel. BeOne Medicines is a global oncology biotechnology company focused on discovering, developing, manufacturing, and commercializing cancer medicines. It offers approved therapies such as BRUKINSA (zanubrutinib) for hematologic malignancies and TEVIMBRA (tislelizumab) for solid tumors, alongside a broad pipeline of investigational agents includingsonrotoclax, BGB-16673, and antibody-drug conjugates. BeOne conducts late-stage clinical trials across blood and solid cancers, operates biologics manufacturing facilities, and runs patient support, expanded access, and clinical trial programs. The company engages in global partnerships and access initiatives to expand availability of its oncology treatments.

Total investments:
1
Last investment:
Lead investor:
100%

Last updated:

Stages BeOne Medicines Ltd. invests in

Series C

Countries BeOne Medicines Ltd. invests in

United States

Contacts

NameEmailPhoneSocials
Joao Barreiro Joao Barreiro
Niyoshi Patel Niyoshi Patel

Sign up to unlock verified contacts

Unlock Contacts

Team

NameTitleInvestmentsLinksEmail
Joao Barreiro
Joao Barreiro Chief Privacy & Data Ethics Officer
Chief Privacy & Data Ethics Officer Total investments: 0 Find email
Niyoshi Patel
Niyoshi Patel Senior Director, Business Development & Investments
Senior Director, Business Development & Investments Total investments: 0 Find email

Investments

CompanyDescriptionRoundLinks
Terremoto Biosciences Terremoto Biosciences
Terremoto Biosciences is a biotechnology company leveraging the power of lysine-based covalency to develop optimized medicines. $108M / Series C / Apr 15, 2026

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Retail
Oil and Gas
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Biotechnology
Software
Legal
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Climate
Fashion
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Music
Art
Real Estate
Sporting Goods
Manufacturing
Publishing
Mobile Apps
Wine and Spirits
Social Media
Financial Services
FinTech
Finance
Franchise
Digital Media
Non Profit
Android
Internet
Proptech
Mobile Advertising
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Zambia
Tajikistan
Romania
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Armenia
Colombia
China
Costa Rica
Kenya
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Panama
Nicaragua
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Morocco
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Paraguay
Canada
Botswana
South Africa
France
Ireland
Denmark
Georgia
Ghana
Iraq
Latvia
Malaysia
Mali
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Spain
Argentina
Europe
Qatar
Angola
Cyprus
Barbados
Belgium
Bangladesh
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Faroe Islands
Ecuador
Jersey
Bolivia
Bahrain
Belize
Algeria
Italy
Belarus
Finland
Hungary
Estonia
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Bahamas
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
Ukraine
San Marino
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

FAQ

How do I contact BeOne Medicines Ltd.?

Public channels for BeOne Medicines Ltd. include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at BeOne Medicines Ltd.?

The team at BeOne Medicines Ltd. includes Joao Barreiro (Chief Privacy & Data Ethics Officer) and Niyoshi Patel (Senior Director, Business Development & Investments). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
BeOne Medicines Ltd. Find emails